U.S. Veterans And Military Gain Access To "Smart" Wound Care Technology

SANTA CLARA, Calif., Nov. 5, 2014 /PRNewswire/ -- OSNovative Systems, Inc. announced today that its award-winning Enluxtra™ wound dressing has been included in the VA federal supply schedule FSS # V797P-4129B  and in the federal prime vendor's DAPA # SP0200-07-H-0043, to be distributed through QB Medical, Inc.

In effect, Enluxtra - a conceptually new product for treating chronic and acute wounds – is now available to the largest national healthcare system with its military hospitals, Department of Defense medical treatment facilities, and more than 1,400 Veteran Care sites serving 9,000,000 veterans every year. OSNovative is proud to provide its U.S.-made product to all clinicians administering acute and chronic wound care to soldiers and veterans.

Wound Care: an Ugly Duckling among High Profile Disorders

Chronic wound management is a matter of national concern, but the scale and significance of the problem are overlooked by the public and the media:

• Wound care carries a $25 billion annual price tag in the U.S. This already huge amount is projected to grow exponentially as diabetes, obesity and old age - major risk factors for developing chronic wounds - affect more and more people each year.¹
• According to the U.S. Department of Veteran Affairs, around 25 percent of military veterans have diabetes (compared to 8 percent of the adult population as a whole).
• Diabetic limb amputation rates for patients in VA hospitals are two times higher than those in public hospitals, four times higher than in private facilities, and veterans wait four times longer to receive treatment.²
• Diabetic foot ulcers double the mortality risk. Multiple sources state that the relative five-year mortality rate after limb amputation is 68 percent - second only to lung cancer (86 percent).

The draining costs of wound care place enormous pressure on all healthcare facilities. Cash-strapped VA hospitals and care sites have everything to gain from a simple, effective and affordable product like Enluxtra that demonstrated impressive clinical results in healing stalled, chronic and acute wounds. Enluxtra succeeds where other treatments fail, and saves limbs from amputation as was documented in multiple case studies.

"Our veterans deserve better," said Scott Simmons, SVP of OSNovative Systems. "They are now fighting an unfair battle with non-combat wounds: in addition to high risk of diabetic ulcers, veterans who survive devastating combat wounds and end up in a wheelchair are also at the greatest risk of developing non-healing pressure ulcers. We are here to help them win this battle."

About Enluxtra

Enluxtra is the exclusive representative of a fundamentally new functional class of smart wound dressings. It was developed by Silicon Valley scientists with a background in nanotechnology and material science and a goal to create an efficient all-purpose dressing. The result is a conceptually new, feedback-driven, polymeric dressing able to detect changes in a wound and adjust its function on the fly.

"There are hundreds of single-function wound dressings available today, but the self-adaptive wound dressing introduces an entirely new category of wound care technology, as the only feedback-driven product on the market that is able to automatically adapt its functions in order to address the ever-changing wound environment – a breakthrough innovative approach," said Dr. Reyzelman, the Co-Director of UCSF Center for Limb Preservation. "What's impressive about this dressing is that you can use it from beginning to end on any wound. Now we can carry one product and use it on almost everything. So far, out of all the things I've tried in all my years – and I've been treating wounds for 15 years – this is as close as it comes to a perfect dressing right now."

Enluxtra Reduces Economic Burden, Simplifies Care

Enluxtra is suitable for any wound at any stage of healing. The dressing eliminates guesswork from wound dressing selection - a challenge that a clinician faces every time they decide on a wound treatment order.

Universal applicability and ease of use mean huge cost savings for any healthcare facility or home care agency through minimized inventory, reduced logistics and inventory control expenses, lower personnel workload and mistakes, and shorter training.

This is godsend for VA facilities that experience severe shortages of both financial and human resources.  Nurses using Enluxtra appreciate its simplicity and the time it saves. With fewer and easier dressing changes (3-5 times less frequent than other brands), nurses are able to care for more patients in less time. Enluxtra does not have to be soaked, it requires no complicated combinations with other products, and, most of the time, a nurse can change the dressing without a physician in attendance. Reduced need for sharp debridement is another added benefit.

The inclusion of Enluxtra in the federal supply product listings reflects OSNovative System's solid market position, its product's exceptional value, and paves the way to achieving better cost-effective care for soldiers and veterans.

About OSNovative Systems
OSNovative Systems, Inc., is a rapidly growing start-up in the Silicon Valley. The company develops, manufactures and sells proprietary devices for advanced wound management and combat/emergency medicine. For more information, visit www.AnyWound.com.

About QB Medical
QB Medical, Inc. is a medical supply distributor located in Chula Vista, Ca. Founded in 2005, QB Medical services over 100 government-funded medical centers. QB Medical is passionate about discovering the most effective medical products for our military service members, veterans, government healthcare providers and patients. 

Sources:
1. Chandan K. Sen, PhD, Gayle M. Gordillo, MD, Sashwati Roy, PhD, Robert Kirsner, MD, Lynn Lambert, CHT, Thomas K. Hunt, MD, Finn Gottrup, MD, Geoffrey C Gurtner, MD, and Michael T. Longaker, MD Human Skin Wounds: A Major and Snowballing Threat to Public Health and the Economy Wound Repair Regen. 2009 Nov–Dec; 17(6): 763–771.
doi:  10.1111/j.1524-475X.2009.00543.x
2. Blumberg SN, Warren SM. Disparities in initial presentation and treatment outcomes of diabetic foot ulcers in a public, private, and Veterans Administration hospital. Journal of Diabetes http://www.ncbi.nlm.nih.gov/pubmed/23551696 2014 Jan;6(1):68-75. doi: 10.1111/1753-0407.12050. Epub 2013 May 29.

Photo - http://photos.prnewswire.com/prnh/20141105/156756

SOURCE OSNovative Systems, Inc.

Related Links

http://www.anywound.com